Ansornitinib
Ansornitinib (ANG-3070) is an oral small molecule inhibitor targeting PDGFR and VEGFR2 (KDR), exhibiting antifibrotic activity. It is utilized in preclinical research to investigate fibrotic diseases, with studies demonstrating its efficacy in both cellular assays and animal models of fibrosis.
Product Specifications
CAS Number
1448874-96-1
Product Name Alternative
PDGFR, VEGFR, ANG3070, ANG-3070, ANG 3070
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.24% (May vary between batches)
Solubility
DMSO:20 mg/mL (37 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.25 mM)
Smiles
C (\NC1=CC=C (N (C (CN2CCN (C) CC2) =O) C) C=C1) (=C\3/C=4C (NC3=O) =NC (C (OC) =O) =CC4) /C5=CC=CC=C5
Molecular Formula
C30H32N6O4
Molecular Weight
540.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-428701-ACT-2 20 µg
Platelet receptor Gi24 CRISPR Activation Plasmid (m2)
Sign In for Pricing
View Details 
